ABL Bio

298380.KQ

128.67 USD

-4.57

-3.43%

Overview

Last close

128.67 usd

Market cap

7.09B usd

52 week high

138.04 usd

52 week low

15.96 usd

Target price

84.42 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

118.4327

Price/Book Value

57.4638

Enterprise Value

7.05B usd

EV/Revenue

117.486

EV/EBITDA

-32.1061

Key financials

Revenue TTM

59.97M usd

Gross Profit TTM

59.93M usd

EBITDA TTM

-18.14M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

167.77M usd

Net debt

N/A usd

About

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is based in Seoul, South Korea.